These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15920339)

  • 41. Value of diagnosis and differential diagnosis of MRI and MR spectroscopy in gliomatosis cerebri.
    Yu A; Li K; Li H
    Eur J Radiol; 2006 Aug; 59(2):216-21. PubMed ID: 16769190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum.
    Mascalchi M; Brugnoli R; Guerrini L; Belli G; Nistri M; Politi LS; Gavazzi C; Lolli F; Argenti G; Villari N
    J Magn Reson Imaging; 2002 Nov; 16(5):532-7. PubMed ID: 12412029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human breast lesions: characterization with proton MR spectroscopy.
    Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
    Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dermoid cysts of the ovary with malignant transformation: MR appearance.
    Kido A; Togashi K; Konishi I; Kataoka ML; Koyama T; Ueda H; Fujii S; Konishi J
    AJR Am J Roentgenol; 1999 Feb; 172(2):445-9. PubMed ID: 9930800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of quantitative proton MR spectroscopy in the differentiation of benign and malignant meningioma.
    Yue Q; Isobe T; Shibata Y; Kawamura H; Anno I; Matsumura A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1103-9. PubMed ID: 22295694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy.
    Okada T; Harada M; Matsuzaki K; Nishitani H; Aono T
    J Magn Reson Imaging; 2001 Jun; 13(6):912-7. PubMed ID: 11382952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible role of single-voxel (1)H-MRS in differential diagnosis of suprasellar tumors.
    Chernov MF; Kawamata T; Amano K; Ono Y; Suzuki T; Nakamura R; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
    J Neurooncol; 2009 Jan; 91(2):191-8. PubMed ID: 18825316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton MR spectroscopy in patients with pyogenic brain abscess: MR spectroscopic imaging versus single-voxel spectroscopy.
    Hsu SH; Chou MC; Ko CW; Hsu SS; Lin HS; Fu JH; Wang PC; Pan HB; Lai PH
    Eur J Radiol; 2013 Aug; 82(8):1299-307. PubMed ID: 23453705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo proton magnetic resonance spectroscopy of human spinal mass lesions.
    Kim YG; Choi GH; Kim DH; Kim YD; Kang YK; Kim JK
    J Spinal Disord Tech; 2004 Oct; 17(5):405-11. PubMed ID: 15385881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preliminary observations and diagnostic value of lipid peak in ovarian thecomas/fibrothecomas using in vivo proton MR spectroscopy at 3T.
    Takeuchi M; Matsuzaki K; Harada M
    J Magn Reson Imaging; 2012 Oct; 36(4):907-11. PubMed ID: 22585396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid Resonance on In Vivo Proton MR Spectroscopy: Value of Other Metabolites in Differential Diagnosis.
    Mohan S; Verma A; Lim CC; Hui F; Kumar S
    Neuroradiol J; 2010 Jun; 23(3):269-78. PubMed ID: 24148583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton MR spectroscopy and the detection of malignancy in ovarian masses.
    Mansour SM; Gomma MMM; Shafik PN
    Br J Radiol; 2019 Sep; 92(1101):20190134. PubMed ID: 31287729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T.
    McLean MA; Priest AN; Joubert I; Lomas DJ; Kataoka MY; Earl H; Crawford R; Brenton JD; Griffiths JR; Sala E
    Magn Reson Med; 2009 Oct; 62(4):855-61. PubMed ID: 19645005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathology of the adnexal mass.
    Bennett JA; Oliva E
    Clin Obstet Gynecol; 2015 Mar; 58(1):3-27. PubMed ID: 25608250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnetic resonance imaging findings of cystic ovarian tumors: major differential diagnoses in five types frequently encountered in daily clinical practice.
    Ohya A; Fujinaga Y
    Jpn J Radiol; 2022 Dec; 40(12):1213-1234. PubMed ID: 35916971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Value of lipid- and water-suppression MR images in distinguishing between blood and lipid within ovarian masses.
    Kier R; Smith RC; McCarthy SM
    AJR Am J Roentgenol; 1992 Feb; 158(2):321-5. PubMed ID: 1729791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 1H Magnetic resonance spectroscopy findings in idiopathic inflammatory myopathies at 3 T: feasibility and first results.
    Subhawong TK; Wang X; Machado AJ; Mammen AL; Christopher-Stine L; Barker PB; Carrino JA; Fayad LM
    Invest Radiol; 2013 Jul; 48(7):509-16. PubMed ID: 23563194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current MR imaging lipid detection techniques for diagnosis of lesions in the abdomen and pelvis.
    Pokharel SS; Macura KJ; Kamel IR; Zaheer A
    Radiographics; 2013 May; 33(3):681-702. PubMed ID: 23674769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.